OTC · CTTH
CTT Pharmaceutical Holdings, Inc.
$0.06+$0.01 (+11.98%)
CTT Pharmaceutical Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 41.1% below the high.
Loading market information…
OTC · PCYN · USD
Stock price, earnings
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Procyon Corporation’s quoted price sits in the lower half of its reported 52-week range, 35.71% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Procyon Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Procyon Corporation, along with its affiliated entities, specializes in the development and distribution of proprietary medical solutions. Their primary focus is on addressing various skin conditions, including pressure and stasis ulcers, general wounds, dermatitis, inflammation, and other dermatological issues, predominantly within the United States. The company offers a diverse array of products. Under the AMERIGEL brand, they provide sophisticated skin and wound healing items such as hydrogel dressings, post-operative surgical kits, saline wound rinses, and protective lotions, in addition to hand sanitizer. Their HELIX3 line features Bioactive Collagen products, available in both powder and matrix forms. For comprehensive wound management, the AMERX brand includes various dressing types like calcium alginate, foam, gauze, and hydrocolloid, as well as complete wound care kits containing components like collagen matrix, collagen powder, foam, and hydrogel. Furthermore, Procyon markets compression garments under the EXTREMIT-EASE name. These offerings are distributed through multiple channels: to institutional clients such as hospitals, wound care clinics, nursing homes, home health agencies, and medical practitioners via distributors, and directly to individual consumers through online sales, direct purchases, and independent or chain pharmacies. Founded in 1987, the company's operations are headquartered in Clearwater, Florida.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:14 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.06+$0.01 (+11.98%)
CTT Pharmaceutical Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 41.1% below the high.
$0.03-$0.00 (0.0%)
Bionoid Pharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 93.3% below the high.
$0.00-$0.00 (-25.0%)
Medical Marijuana, Inc.’s quoted price sits in the lower half of its reported 52-week range, 62.5% below the high.
$0.00$0.00 (0.0%)
Opus Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
$0.01$0.00 (0.0%)
Ovation Science Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.13% below the high.
$0.02$0.00 (0.0%)
Health Logic Interactive Inc.’s quoted price sits in the upper half of its reported 52-week range, 45.21% below the high.
$0.00$0.00 (0.0%)
Endexx Corporation’s quoted price sits in the lower half of its reported 52-week range, 99.75% below the high.
$0.00$0.00 (0.0%)
BioTech Medics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.65% below the high.
